Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sex differences in type 2 diabetes
Alexandra Kautzky‐Willer, Michael Leutner, Jürgen Harreiter
Diabetologia (2023) Vol. 66, Iss. 6, pp. 986-1002
Open Access | Times Cited: 247

Showing 1-25 of 247 citing articles:

Insights and implications of sexual dimorphism in osteoporosis
Yuanyuan Zhang, Na Xie, Xiaodong Sun, et al.
Bone Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, et al.
Diabetologia (2024) Vol. 67, Iss. 7, pp. 1206-1222
Open Access | Times Cited: 29
Global, regional, and national burden of type 2 diabetes mellitus caused by high BMI from 1990 to 2021, and forecasts to 2045: analysis from the global burden of disease study 2021
Xin Huang, Yanyan Wu, Yulu Ni, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access | Times Cited: 3
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Darren K. McGuire, Nikolaus Marx, Sharon L. Mulvagh, et al.
New England Journal of Medicine (2025)
Closed Access | Times Cited: 3
Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis
Song Liu, Jiaqiang Hu, Chen Zhao, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access | Times Cited: 2
Relationship between advanced lung cancer inflammation index and long-term all-cause, cardiovascular, and cancer mortality among type 2 diabetes mellitus patients: NHANES, 1999–2018
Yaying Chen, Mengqian Guan, Ruiqi Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 36
Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022
Yikuan Du, Jinfeng Zhu, Zhuoming Guo, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 189-201
Closed Access | Times Cited: 15
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet
Roberta Rinaldi, Sara De Nucci, Rossella Donghia, et al.
Nutrients (2024) Vol. 16, Iss. 10, pp. 1408-1408
Open Access | Times Cited: 13
Association of triglyceride glucose index and triglyceride glucose-body mass index with sudden cardiac arrest in the general population
Shuijing Zhang, Wenbing Liu, Bin Xu, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Reproductive and Oncologic Outcomes in Young Women with Stage IA and Grade 2 Endometrial Carcinoma Undergoing Fertility-Sparing Treatment: A Systematic Review
Andrea Etrusco, Antonio Simone Laganà, Vito Chiàntera, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 306-306
Open Access | Times Cited: 12
Reproductive risk factors across the female lifecourse and later metabolic health
Amy R. Nichols, Jorge E. Chavarro, Emily Oken
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 240-262
Open Access | Times Cited: 10
Normal triglyceride concentration and the risk of diabetes mellitus type 2 in the general population of China
Rubing Guo, Lianhua Wei, Yongtong Cao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
Sex-specific associations of environmental exposures with prevalent diabetes and obesity – Results from the KORA Fit study
Fiona Niedermayer, Kathrin Wolf, Siqi Zhang, et al.
Environmental Research (2024) Vol. 252, pp. 118965-118965
Open Access | Times Cited: 8
Diabetes in China part 1: epidemiology and risk factors
Yu Xu, Jieli Lu, Mian Li, et al.
The Lancet Public Health (2024)
Open Access | Times Cited: 8
The sex-specific effects of RAGE signaling and Type 2 Diabetes on mouse cortical bone mechanics, structure, and material properties
Timothy K. Hung, Kaitlyn S. Broz, Remy E. Walk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Diabetes and gut microbiome
K. Fliegerová, Tiziana Maria Mahayri, Hana Sechovcová, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access | Times Cited: 1
A sex-disaggregated analysis of the prognostic value of lean type 2 diabetes mellitus in the adult population with acute myocardial infarction
Gwyneth Kong, Jaycie Koh, J I A E E Chia, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The role of estrogen and ER stress in glycemic regulation in the sexually dimorphic TALLYHO/JngJ mouse model of diabetes
Monica De Paoli, Zinal Patel, Susanna Fang, et al.
Journal of the Endocrine Society (2025) Vol. 9, Iss. 5
Open Access | Times Cited: 1
Landscape of sex differences in obesity and type 2 diabetes in subcutaneous adipose tissue: a systematic review and meta-analysis of transcriptomics studies
Roxana Andreea Moldovan, Marta R. Hidalgo, Helena Castañé, et al.
Metabolism (2025), pp. 156241-156241
Closed Access | Times Cited: 1
Hyperglycemia in Hospital: An Independent Marker of Infection, Acute Kidney Injury, and Stroke for Hospital Inpatients
Rahul Barmanray, Mervyn Kyi, Leon J. Worth, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 11, pp. e2048-e2056
Open Access | Times Cited: 6
Sex differences in adipose insulin resistance are linked to obesity, lipolysis and insulin receptor substrate 1
Peter Arner, Nathalie Viguerie, Lucas Massier, et al.
International Journal of Obesity (2024) Vol. 48, Iss. 7, pp. 934-940
Open Access | Times Cited: 6
A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data
Yikuan Du, Mengting Zhang, Zhenjie Wang, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 10, pp. 1422-1433
Open Access | Times Cited: 6
The challenges of assessing adiposity in a clinical setting
Emma Börgeson, Saeideh Tavajoh, Stephan Lange, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 615-626
Closed Access | Times Cited: 6
GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates
Deanne H. Hryciw, Rhiannon K. Patten, Raymond J. Rodgers, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 3, pp. 183-190
Closed Access | Times Cited: 5
Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people
Carolin T. Lehner, Marian Eberl, Ewan Donnachie, et al.
Diabetologia (2024) Vol. 67, Iss. 6, pp. 1040-1050
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top